---
title: "Incannex starts screening patients in Phase 2 DReAMzz trial of IHL-42X for sleep apnea"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293607970.md"
description: "Incannex Healthcare has initiated patient screening for its Phase 2 DReAMzz trial of IHL-42X, a treatment for obstructive sleep apnea. The company reports that initial sites are active, with more expected as approvals are secured. IHL-42X holds FDA Fast Track designation, potentially expediting the path to Phase III development. Prior Phase 2 results indicated an up to 83% reduction in the apnea-hypopnea index and improved patient-reported outcomes."
datetime: "2026-07-23T11:32:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293607970.md)
  - [en](https://longbridge.com/en/news/293607970.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293607970.md)
generator: "portal-rs"
---

# Incannex starts screening patients in Phase 2 DReAMzz trial of IHL-42X for sleep apnea

-   Incannex began screening participants in its DReAMzz Phase 2 dose-confirmation trial of IHL-42X for obstructive sleep apnea. \* First sites are screening now; additional sites are expected to start as approvals are secured. \* IHL-42X holds FDA Fast Track designation, supporting a potentially expedited regulatory path ahead of planned Phase III development. \* Incannex cited prior Phase 2 results showing up to 83% reduction in apnea-hypopnea index, with improvements in patient-reported outcomes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incannex Healthcare Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-080622), on July 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [IXHL.US](https://longbridge.com/en/quote/IXHL.US.md)

## Related News & Research

- [Incannex wins US patent for IHL-42X obstructive sleep apnea therapy](https://longbridge.com/en/news/290824124.md)
- [Incannex Secures A$5.1M R&D Tax Incentive Refund](https://longbridge.com/en/news/295535573.md)
- [Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026 | AVLN Stock News](https://longbridge.com/en/news/296823873.md)
- [Vivos Opens New Henderson Sleep Testing and Treatment Center](https://longbridge.com/en/news/296656579.md)
- [Richardson Electronics (NASDAQ:RELL) Director Kenneth Halverson Sells 1,500 Shares of Stock](https://longbridge.com/en/news/296814822.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**